SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--iPierian, Inc., announced today that it has appointed Pamela B. Conley, PhD, as its Vice President of Research. Pamela will be responsible for iPierian’s emerging drug development pipeline for therapeutics to treat neurodegenerative diseases, as well as the company’s proprietary patient-derived induced pluripotent stem cell (iPSC) platform which provides insight for novel therapeutic targets or mechanisms of disease.
